Europe postpones decision on Bristol immune system cancer drug
March 27, 2015 at 08:49 AM EDT
LONDON, March 27 (Reuters) - European regulators have postponed a decision on whether to recommend approval of a closely watched Bristol-Myers Squibb drug that helps the immune system fight cancer, a spokeswoman for the European Medicines Agency said on Friday.